{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:48:53Z","timestamp":1789019333773,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.atherosclerosis.2014.12.036","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T00:16:52Z","timestamp":1419293812000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience"],"prefix":"10.1016","volume":"239","author":[{"given":"Damon A.","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8499-4537","authenticated-orcid":false,"given":"Sally","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"van Bockxmeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"O'Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib1","series-title":"Principles and Practice of Mass Screening for Disease","author":"Wilson","year":"1968"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.036_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosissup.2011.06.001","article-title":"Familial hypercholesterolaemia: a model of care for Australasia","volume":"12","author":"Watts","year":"2011","journal-title":"Atheroscler. Suppl."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.036_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/PAT.0b013e32834efa07","article-title":"Screening for familial hypercholesterolaemia","volume":"44","author":"Bender","year":"2012","journal-title":"Pathology"},{"issue":"45","key":"10.1016\/j.atherosclerosis.2014.12.036_bib4","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.036_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(02)00330-1","article-title":"A\u00a0review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia","volume":"168","author":"Marks","year":"2003","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.036_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCGENETICS.111.962456","article-title":"Discriminative ability of LDL-cholesterol to identify patients with familial hypercholesterolemia: a cross-sectional study in 26,406 individuals tested for genetic FH","volume":"5","author":"Huijgen","year":"2012","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib7","series-title":"Familial Hypercholesterolaemia (FH): Report of a Second WHO Consultation. Geneva","author":"World Health Organisation","year":"1999"},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","author":"Scientific Steering Committee of behalf of Simon Broome Register Group","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolaemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.036_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.5551\/jat.14159","article-title":"Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan","volume":"19","author":"Harada-Shiba","year":"2012","journal-title":"J.\u00a0Atheroscler. Thromb."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2014.12.036_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwh236","article-title":"Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review","volume":"160","author":"Austin","year":"2004","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.036_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","article-title":"Mechanisms of disease: genetic causes of familial hypercholesterolemia","volume":"4","author":"Soutar","year":"2007","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.036_bib13","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2012.07.030","article-title":"Genetic analysis of familial hypercholesterolaemia in Western Australia","volume":"224","author":"Hooper","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.036_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2011.06.016","article-title":"Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization","volume":"218","author":"Descamps","year":"2011","journal-title":"Atherosclerosis"},{"issue":"3 Suppl.\u00a0l","key":"10.1016\/j.atherosclerosis.2014.12.036_bib15","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Daniels","year":"2011","journal-title":"J.\u00a0Clin. Lipidol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.036_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.036_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","article-title":"Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia","volume":"8","author":"Ademi","year":"2014","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib18","series-title":"NICE Clinical Guideline 71: Identification and Management of Familial Hypercholesterolaemia","author":"National Institute for Health and Clinical Excellence and The National Collaborating Centre for Primary Care","year":"2008"},{"issue":"9251","key":"10.1016\/j.atherosclerosis.2014.12.036_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib20","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/bmj.321.7275.1497","article-title":"Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia","volume":"321","author":"Bhatnagar","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib21","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"issue":"9753","key":"10.1016\/j.atherosclerosis.2014.12.036_bib22","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.036_bib23","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metabol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.036_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2014.12.036_bib25","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.036_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-2004-822989","article-title":"Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program","volume":"4","author":"Leren","year":"2004","journal-title":"Semin. Vasc. Med."},{"issue":"1326","key":"10.1016\/j.atherosclerosis.2014.12.036_bib27","first-page":"97","article-title":"Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand","volume":"123","author":"Muir","year":"2010","journal-title":"N.\u00a0Z. Med. J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.036_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.atherosclerosis.2007.07.019","article-title":"Familial hypercholesterolaemia in Portugal","volume":"196","author":"Bourbon","year":"2008","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.036_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajmg.a.34368","article-title":"The evaluation of cascade testing for familial hypercholesterolemia","volume":"158A","author":"Morris","year":"2012","journal-title":"Am. J. Med. Genet. A"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.036_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosis.2014.11.009","article-title":"Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects","volume":"238","author":"Jannes","year":"2014","journal-title":"Atherosclerosis"},{"issue":"7349","key":"10.1016\/j.atherosclerosis.2014.12.036_bib31","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.324.7349.1303","article-title":"Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia","volume":"324","author":"Marks","year":"2002","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.036_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1744-1609.2012.00272.x","article-title":"Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations","volume":"10","author":"Watts","year":"2012","journal-title":"Int. J. Evid. Based Healthc."},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib33","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ijcard.2013.01.280","article-title":"A\u00a0systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia","volume":"167","author":"Ademi","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib34","first-page":"1","article-title":"Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment","author":"Hardcastle","year":"2014","journal-title":"Int. J. Behav. Med."},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1258\/096914106778440617","article-title":"Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes","volume":"13","author":"Marks","year":"2006","journal-title":"J.\u00a0Med. Screen."},{"issue":"Pt 1","key":"10.1016\/j.atherosclerosis.2014.12.036_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1258\/acb.2008.008094","article-title":"Family tracing to identify patients with familial hypercholesterolaemia: the second audit of the Department of Health Familial Hypercholesterolaemia Cascade Testing Project","volume":"46","author":"Hadfield","year":"2009","journal-title":"Ann. Clin. Biochem."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.036_bib37","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ijcard.2012.03.048","article-title":"Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases","volume":"167","author":"Hu","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.036_bib38","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1399-0004.2009.01356.x","article-title":"Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project","volume":"77","author":"Taylor","year":"2010","journal-title":"Clin. Genet."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.036_bib39","doi-asserted-by":"crossref","first-page":"E1811","DOI":"10.1002\/humu.21348","article-title":"Molecular spectrum of autosomal dominant hypercholesterolemia in France","volume":"31","author":"Marduel","year":"2010","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.036_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.atherosclerosis.2010.07.012","article-title":"Update of the Portuguese familial hypercholesterolaemia study","volume":"212","author":"Medeiros","year":"2010","journal-title":"Atherosclerosis"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2014.12.036_bib41","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur. Heart J."},{"issue":"25 Suppl.\u00a02","key":"10.1016\/j.atherosclerosis.2014.12.036_bib42","first-page":"S1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.036_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.hlc.2013.08.005","article-title":"Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in western Australia","volume":"23","author":"Bell","year":"2014","journal-title":"Heart Lung Circ."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.036_bib44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/clc.22223","article-title":"Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice","volume":"37","author":"Foody","year":"2014","journal-title":"Clin. Cardiol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.036_bib45","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/clc.22257","article-title":"Response to familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice","volume":"37","author":"Bell","year":"2014","journal-title":"Clin. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.036_bib46","doi-asserted-by":"crossref","first-page":"e9220","DOI":"10.1371\/journal.pone.0009220","article-title":"Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal","volume":"5","author":"Huijgen","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.036_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2009.09.014","article-title":"Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands","volume":"209","author":"Pijlman","year":"2010","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.036_bib48","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.18.6.1007","article-title":"Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia","volume":"18","author":"Couture","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2014.12.036_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01213011-200504000-00005","article-title":"Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia","volume":"15","author":"Miltiadous","year":"2005","journal-title":"Pharm. Genomics"},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib50","series-title":"Clinical Guideline 71: Identification and Management of Familial Hypercholesterolaemia","author":"NICE","year":"2008"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2014.12.036_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J.\u00a0Clin. Lipidol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.12.036_bib52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ahj.2014.03.019","article-title":"A\u00a0systematic review of statin-induced muscle problems in clinical trials","volume":"168","author":"Ganga","year":"2014","journal-title":"Am. Heart J."},{"issue":"3 Suppl.\u00a0l","key":"10.1016\/j.atherosclerosis.2014.12.036_bib53","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jacl.2014.03.004","article-title":"An assessment by the Statin Muscle Safety Task Force: 2014 update","volume":"8","author":"Rosenson","year":"2014","journal-title":"J.\u00a0Clin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib54","series-title":"F.S.l., Saving Families. The Health, Social and Economic Advantages of Detecting and Treating Familial Hypercholesterolaemia (FH)","author":"Heart UK","year":"2012"},{"key":"10.1016\/j.atherosclerosis.2014.12.036_bib55","article-title":"PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial","author":"Raal","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2014.12.036_bib56","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2014.12.036_bib57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2007.12.024","article-title":"Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors","volume":"200","author":"Alonso","year":"2008","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.12.036_bib58","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J.\u00a0Intern. Med."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.12.036_bib59","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.5551\/jat.14621","article-title":"Guidelines for the management of familial hypercholesterolemia","volume":"19","author":"Harada-Shiba","year":"2012","journal-title":"J.\u00a0Atheroscler. Thromb."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2014.12.036_bib60","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2014.12.036_bib61","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.hlc.2014.07.062","article-title":"Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services","volume":"23","author":"Vickery","year":"2014","journal-title":"Heart Lung Circ."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501401658X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501401658X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:35:53Z","timestamp":1758155753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501401658X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S002191501401658X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.036","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}